ArticleScientific reports2025
Association of bioelectrical impedance phase angle with exercise tolerance in patients with chronic thromboembolic pulmonary hypertension.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The relationship between exercise tolerance and body composition in chronic thromboembolic pulmonary hypertension (CTEPH) is not well-understood. This study assessed body composition and its link to the 6-min walk distance (6MWD) in 181 patients with CTEPH, analyzing 257 health status assessments from 2018 to 2021. Patients underwent right heart catheterization, bioelectrical impedance analysis for body composition, and 6MWD evaluations. The mean pulmonary arterial pressure and 6MWD were 20 mmHg (interquartile range [IQR]:16–25) and 414 m (IQR:354–490), respectively. The skeletal muscle index (SMI) and phase angle (PhA) were 6.4 kg/m2 (IQR: 5.7–7.2) and 4.4° (IQR: 4.0–5.1), respectively. The 6MWD was associated with age (β = –0.19; 95% confidence interval [CI]: –0.32, –0.07; p = 0.003), male sex (β = 0.22; 95% CI: 0.10, 0.34; p < 0.001), mean pulmonary arterial pressure (β = –0.32; 95% CI: –0.42, –0.21; p < 0.001), and PhA (β = 0.21; 95% CI: 0.06, 0.36; p = 0.005). However, SMI did not show any association with 6MWD. The study suggests PhA as a potential simple marker for exercise tolerance in patients with CTEPH, pending further validation for therapeutic targeting.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.